satavaptan has been researched along with furosemide in 5 studies
| Studies (satavaptan) | Trials (satavaptan) | Recent Studies (post-2010) (satavaptan) | Studies (furosemide) | Trials (furosemide) | Recent Studies (post-2010) (furosemide) |
|---|---|---|---|---|---|
| 95 | 11 | 30 | 13,631 | 1,358 | 2,486 |
| Protein | Taxonomy | satavaptan (IC50) | furosemide (IC50) |
|---|---|---|---|
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 3.76 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Mus musculus (house mouse) | 3.76 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bankir, L; Barberis, C; Brossard, G; Chicot, D; Foulon, L; Galindo, G; Garcia, C; Garcia, G; Guillon, G; Jard, S; Lacour, C; Le Fur, G; Maffrand, JP; Marty, E; Nisato, D; Pouzet, B; Raufaste, D; Serradeil-Le Gal, C; Valette, G; Vilain, P | 1 |
| Bankir, L; Bardoux, P; Bichet, DG; Bouby, N; Perucca, J | 1 |
| Laczi, F | 1 |
| Haass, M | 1 |
| Bruha, R; Dudley, F; Ginès, P; Terg, R; Watson, H; Wong, F; Zarski, JP | 1 |
2 review(s) available for satavaptan and furosemide
| Article | Year |
|---|---|
[Etiology, diagnostics and therapy of hyponatremias].
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins | 2008 |
[Vasopressin receptor antagonists and heart failure].
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan | 2009 |
1 trial(s) available for satavaptan and furosemide
| Article | Year |
|---|---|
Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Body Weight; Diuretics; Double-Blind Method; Drug Combinations; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Morpholines; Prospective Studies; Spiro Compounds; Spironolactone; Treatment Outcome | 2010 |
2 other study(ies) available for satavaptan and furosemide
| Article | Year |
|---|---|
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
Topics: Adenylyl Cyclases; Administration, Oral; Adrenal Glands; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Autoradiography; Benzazepines; Binding, Competitive; Furosemide; Hydrochlorothiazide; Kidney; Molecular Structure; Morpholines; Potassium; Rats; Sodium; Spiro Compounds; Urine | 1996 |
Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Deamino Arginine Vasopressin; Diuretics; Dose-Response Relationship, Drug; Furosemide; Male; Morpholines; Rats; Rats, Wistar; Receptors, Vasopressin; Sodium; Spiro Compounds; Urine | 2008 |